Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
07/25/14 Amgen (AMGN) Nexavar for Breast Cancer Subscribers Only Subscribers Only     Subscribers Only
07/25/14 Novogen (NVGN) Cantrixil for Ovarian Cancer Subscribers Only Subscribers Only     Subscribers Only
07/25/14 Otsuka (4768:JP) S-1 for Hepatocellular (Liver) Cancer (HCC) (including secondary metastases) Subscribers Only Subscribers Only     Subscribers Only
07/24/14 Keryx (KERX) Zerenex for Hyperphosphatemia Subscribers Only Subscribers Only     Subscribers Only
07/24/14 MacroGenics (MGNX) MGD007 for Colorectal Cancer (CRC) Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/25/14 Subscribers Only Subscribers Only Company - Earnings Announcement
07/25/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 07/26/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 07/26/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
07/27/14 Subscribers Only Subscribers Only Patent - Expiration